Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kavita Gumbhir-Shah"'
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 12:353-362
Objectives of this study were to compare the pharmacokinetics, pharmacodynamics and safety of single cumulative doses of active (R)-salbutamol given either as the single enantiomer or racemic mixture by inhalation to subjects with mild to moderate as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::439c591d372f71aa2b7a1b0dbffe459f
https://doi.org/10.1006/pupt.1999.0217
https://doi.org/10.1006/pupt.1999.0217
Publikováno v:
The Journal of Clinical Pharmacology. 38:1096-1106
The pharmacokinetics and pharmacodynamics of inhaled albuterol given as single or multiple doses of racemate (RS-) or single enantiomers (R-, S-) were determined. In an open-label, three-way crossover, parallel-dose study, 1.25 and 5 mg of (R)- and (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbf68b8bcf1d1b52545acfcd0dd0f0f7
https://doi.org/10.1177/009127009803801203
https://doi.org/10.1177/009127009803801203
Autor:
Joan M. Korth-Bradley, C E Halstenson, Kavita Gumbhir-Shah, Sheryl A Decleene, William H. Cevallos
Publikováno v:
Annals of Pharmacotherapy. 31:395-399
Objective To estimate absolute bioavailability of bromfenac and to compare its pharmacokinetics after intravenous and oral administration. Design This was a randomized, open-label, single-dose, crossover study conducted under fasting conditions with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034d1bce021c86c525f57982f75f5aea
https://doi.org/10.1177/106002809703100401
https://doi.org/10.1177/106002809703100401
Publikováno v:
The Journal of Clinical Pharmacology. 37:160-168
An open-label, nonrandomized, multiple-dose, inpatient study was conducted in healthy male volunteers to compare the pharmacokinetics of bromfenac and phenytoin when the drugs are given individually and concomitantly. Twelve men received multiple ora
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc685847d319ce41ee8f679517b51d62
https://doi.org/10.1002/j.1552-4604.1997.tb04775.x
https://doi.org/10.1002/j.1552-4604.1997.tb04775.x
Autor:
dawn harper, mark lupher, Marlies S. Wijsenbeek, John Getsy, kavita gumbhir-shah, maya levy, Adam F. Cohen, Bernt van den Blink, ingrid de visser, Jacobus Burggraaf, Matthijs Moerland
Publikováno v:
B102. INTERSTITIAL LUNG DISEASE: NOVEL MANAGEMENT AND OUTCOME STRATEGIES.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1576ff4a802ff6c677f7bae14040e1f8
https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3803
https://doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3803
Publikováno v:
Biopharmaceuticsdrug disposition. 25(2)
This was an open-label, randomized, three-period, three-treatment, multiple dose, crossover study in 12 healthy male and female subjects. This study evaluated single dose and steady-state pharmacokinetics of fluvastatin following single and multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a5db6572ae06ed62157f3fbf9a41b8e
https://pubmed.ncbi.nlm.nih.gov/14872552
https://pubmed.ncbi.nlm.nih.gov/14872552
Publikováno v:
Biopharmaceutics & Drug Disposition; Mar2004, Vol. 25 Issue 2, p51-59, 9p